THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers Meeting Abstract


Authors: Narayan, S.; Swanson, N.; Drain, A.; Gareau, K.; Rouillard, N.; Liang, J.; Liu, H. W.; Brown, L.; Lamothe, R.; Greenberg, P. D.; Klebanoff, C. A.; Gupta, A.; Hallet, D.; Shapiro, G.; Nguyen, K.; Vincent, L.
Abstract Title: THRIVE(TM) non-viral targeted transgene knock-in platform generates specific and potent TCR T cell products for the treatment of solid cancers
Meeting Title: 27th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)
Journal Title: Molecular Therapy
Volume: 32
Issue: 4 Suppl. 1
Meeting Dates: 2024 May 7-11
Meeting Location: Baltimore, MD
ISSN: 1525-0016
Publisher: Nature Publishing Group  
Date Published: 2024-04-22
Start Page: 416
Language: English
ACCESSION: WOS:001332783401425
PROVIDER: wos
DOI: 10.1016/j.ymthe.2024.04.020
Notes: Meeting Abstract: 836 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors